Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

COMPLETED
Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy
Description

The purpose of the study is to evaluate the effectiveness of the oral nutritional therapy serum-derived bovine immunoglobulin protein isolate (SBI) 2.5 g twice a day (BID) and SBI 5.0 g versus placebo on supporting nutrient absorption in HIV+ subjects with HIV-associated enteropathy.

COMPLETED
Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea
Description

This study is being conducted to evaluate the safety and tolerability of crofelemer 125 mg twice a day, taken orally, over 48 weeks of therapy in human immunodeficiency virus-positive (HIV+) subjects with diarrhea.